Oxaliplatin Induced Pulmonary Fibrosis: a Case Report

Pavlović, Mirjana; Šeparović, Robert; Silovski, Tajana; Tečić Vuger, Ana; Jurić, Andreja

doi:10.20471/acc.2020.59.04.25

Pregled bibliografske jedinice broj: 1128316

Oxaliplatin Induced Pulmonary Fibrosis: a Case Report

Pavlović, Mirjana; Šeparović, Robert; Silovski, Tajana; Tečić Vuger, Ana; Jurić, Andreja

Oxaliplatin Induced Pulmonary Fibrosis: a Case Report // Acta clinica Croatica, 59 (2020), 4; 761-764 doi:10.20471/acc.2020.59.04.25 (međunarodna recenzija, članak, ostalo)

CROSBI ID: 1128316 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Oxaliplatin Induced Pulmonary Fibrosis: a Case Report

Autori
Pavlović, Mirjana ; Šeparović, Robert ; Silovski, Tajana ; Tečić Vuger, Ana ; Jurić, Andreja

Izvornik
Acta clinica Croatica (0353-9466) 59 (2020), 4; 761-764

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo

Ključne riječi
Oxaliplatin ; Colon cancer ; Side effects ; Pulmonary fibrosis ; Interstitial lung disease

Sažetak
Oxaliplatin is part of the standard chemotherapy regimens for treating colorectal carcinoma. Pulmonary fibrosis is a serious but rare side effect of oxaliplatin treatment, which resulted in patient death in more than half of the reported cases. The precise pathophysiological mechanism of this phenomenon has not been clarified yet. Analysis of the reported cases strongly suggests that early diagnosis and immediate corticosteroid treatment are crucial for better prognosis. Here we re- port a case of pulmonary fibrosis related to the FOLFOX regimen in a patient with early colorectal carcinoma.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti

POVEZANOST RADA

Ustanove:
Klinika za tumore,
Klinički bolnički centar Zagreb

Profili:

Mirjana Pavlović (autor)